• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Chris Newmarker

Tandem Diabetes Care wins FDA clearance for insulin dosing via smartphone app

February 16, 2022 By Chris Newmarker

Tandem mobile bolus

Tandem Diabetes Care (NASDAQ:TNDM) today announced FDA clearance of bolus insulin dosing on the t:slim X2 insulin pump using the t:connect mobile app. Company officials said the t:connect mobile app is now the first FDA-cleared smartphone app for insulin delivery on both the iOS and Android operating systems. Tandem Diabetes Care plans to roll out […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA) Tagged With: Tandem Diabetes Care

TriMas completes purchase of Omega Plastics

December 20, 2021 By Chris Newmarker

TriMas Omega Plastics

TriMas (NASDAQ: TRS) announced today that it has completed its acquisition of medical device components maker Omega Plastics. The financial terms of the deal were not disclosed. Omega (Clinton Township, Michigan) expects to bring in $18 million in revenue in fiscal year 2021. Omega Plastics boasts core injection molding capabilities, an ISO Class 8 clean […]

Filed Under: Business/Financial News, Contract Services, Featured Tagged With: Omega Plastics, TriMas

ICU Medical’s Smiths Medical acquisition remains on track

November 19, 2021 By Chris Newmarker

ICU Medical Smiths Medical

ICU Medical (NASDAQ:ICUI) is a step closer to acquiring Smiths Medical after clearing a shareholders vote at Smiths’ British parent company, the Smiths Group. Almost all of the nearly 327 million Smiths Group shareholders voting on November 17 approved the $2.35 billion buy. Get the full story on our sister site Medical Tubing + Extrusion. 

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Hospital Care, Vascular Tagged With: ICU Medical, Smiths Medical

BD handily beats The Street in Q2 — but notes some delta variant effects

August 5, 2021 By Chris Newmarker

BD

BD (NYSE: BDX) posted second-quarter results today that beat the consensus forecast on Wall Street, increasing its full-year guidance. The medtech giant, however, also acknowledged that it’s seeing the COVID-19 delta variant impact elective procedure volumes in some U.S. states. Get the full story on our sister site MassDevice. 

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: BD

Pharma 50: Here’s how the world’s largest pharma companies are doing

May 12, 2021 By Chris Newmarker

Pharma 50 50 largest pharma companies pharmaceutical

The global pharmaceutical industry held up well during the pandemic, with 10 of the largest businesses only seeing a roughly –3% drop in revenue in 2020. Eight of the 10 even came out ahead. That’s one of the big takeaways from our sister publication Drug Discovery & Development’s inaugural Pharma 50, a compilation of data […]

Filed Under: Featured, Pharmaceuticals Tagged With: AstraZeneca plc, Gilead Sciences, GlaxoSmithKline plc, Janssen Pharmaceuticals, Johnson & Johnson, Merck, Novartis, Pfizer Inc., Pharma 50, Roche, sanofi, Sinopharm

BD to spin off its diabetes business, Q2 earnings beat The Street

May 6, 2021 By Chris Newmarker

BD

BD (NYSE: BDX) announced today that it will spin off its Diabetes Care business as an independent, publicly traded company during the first half of 2022. The Diabetes Care business saw $1.1 billion in sales during BD’s fiscal year ended Sept. 30, 2020, nearly half outside the U.S. The business manufactures roughly 8 billion injection […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: BD, Becton Dickinson

BrightInsight raises $101M for its pre-built digital health platform

March 30, 2021 By Chris Newmarker

BrightInsight

BrightInsight announced today that it’s raised $101 million in a Series C round led by VC firm General Catalyst. The money will go toward more hiring and further accelerating the work BrightInsight is conducting with customers to support their digital health product launches. The San Jose, Calif.–based company offers a turnkey digital health platform for […]

Filed Under: Contract Services, Featured, Funding Roundup, mHealth (Mobile Health), Patient Monitoring, Research & Development Tagged With: BrightInsight, General Catalyst

Dexcom promotes Jereme Sylvain to CFO

March 23, 2021 By Chris Newmarker

Dexcom updated logo

Dexcom (NASDAQ: DXCM) announced today that it has promoted Jereme Sylvain to become a new EVP and CFO at the continuous glucose monitoring company. Sylvain — who joined Dexcom in 2018 and was most recently SVP of finance and chief accounting officer — will report to COO Quentin Blackford. Previously, Blackford had been serving as […]

Filed Under: Business/Financial News, Diabetes, Featured, Personnel Tagged With: CGM, continuous glucose monitor, Dexcom, Personnel Moves

Vertex Pharmaceuticals wins FDA fast track designation for its cell-based diabetes treatment

March 10, 2021 By Chris Newmarker

Vertex Pharmaceuticals

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today that FDA has granted fast track designation for its VX-880, an investigational human stem cell-derived islet cell therapy for type 1 diabetes. Vertex has begun a clinical trial for VX-880 (formerly known as STx-02) in patients with type 1 diabetes (T1D) with severe hypoglycemia and impaired hypoglycemic awareness. “Ours […]

Filed Under: Clinical Trials, Diabetes, Featured, Pharmaceuticals Tagged With: Vertex Pharmaceuticals

Baxter to make Moderna COVID-19 vaccine in US

March 9, 2021 By Chris Newmarker

Baxter Moderna

Baxter announced that its Baxter BioPharma Solutions business will make Moderna‘s COVID-19 vaccine at its fill/finish sterile manufacturing facilities in Bloomington, Ind. The plan — announced yesterday — is for Baxter to make 60–90 million doses of the Moderna vaccine in 2021. “We have seen a remarkable demonstration of scientific and health care expertise in […]

Filed Under: Contract Services, Featured Tagged With: Baxter, coronavirus, COVID-19, Moderna

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 9
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS